Immuno-Autonomics as a Complement to Precision Medicine Guiding Treatment of Patients With Rheumatoid Arthritis: Comment on the Article by Tao et al

Affiliations

Comment

Andrew J Holman. Arthritis Rheumatol. 2021 Oct.

. 2021 Oct;73(10):1945-1946.

doi: 10.1002/art.41782. Epub 2021 Aug 17.

No abstract available

Comment on

Multiomics and Machine Learning Accurately Predict Clinical Response to Adalimumab and Etanercept Therapy in Patients With Rheumatoid Arthritis.
Tao W, Concepcion AN, Vianen M, Marijnissen ACA, Lafeber FPGJ, Radstake TRDJ, Pandit A. Tao W, et al. Arthritis Rheumatol. 2021 Feb;73(2):212-222. doi: 10.1002/art.41516. Epub 2020 Dec 26. Arthritis Rheumatol. 2021. PMID: 32909363 Free PMC article.

1. Tao W, Concepcion AN, Vianen M, Marijnissen AC, Lafeber FP, Radstake TR, et al. Multiomics and machine learning accurately predict clinical response to adalimumab and etanercept therapy in patients with rheumatoid arthritis. Arthritis Rheumatol 2021;73:212-22.
1. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
1. Taylor PC, Holman AJ. Rheumatoid arthritis and the emergence of immuno-autonomics. Rheumatology (Oxford) 2019;58:2079-80.
1. Yadav RK, Gupta R, Deepak KK. A pilot study on short term heart rate variability & its correlation with disease activity in Indian patients with rheumatoid arthritis. Indian J Med Res 2012;136:593-8.
1. Koopman FA, Tang MW, Vermeij J, de Hair MJ, Choi IY, Vervoordeldonk MJ, et al. Autonomic dysfunction precedes development of rheumatoid arthritis: a prospective cohort study. EBioMedicine 2016;6:231-7.